Changes in retrobulbar ocular hemodynamics and visual function in low tension glaucoma patients after six months of treatment with nifedipine

D. W. Evans, Alon Harris, Louis Cantor, R. Wilson, B. J. Martin

Research output: Contribution to journalArticle

Abstract

Purpose. Reduced ocular blood flow, possibly from ocular vasospasm, has been suggested as a cause for vision loss associated with normal-tension glaucoma (NTG). Calcium channel blocking agents have recently been proposed as treatment for ocular vasospasm. Methods. Color Doppler imaging (CDI) of the ophthalmic, central retinal and short posterior ciliary arteries, visual field sensitivity and static spatial contrast sensitivity were evaluated for sixteen NTG patients (9 Female/ 7 Male: Age 58.8 ± 15 years) after 3 weeks of drug washout and again following 6 months of treatment with nifedipine. Results. Nifedipine did not alter IOP, blood pressure or heart rate. The drug left peak systolic velocity, end diastolic velocity and resistive index in each retrobulbar vessel unaltered. Visual field sensitivity and contrast sensitivity (CS) at 3 spatial frequencies also showed no change. CS did, however, improve significantly at 6 cpd (p = .004). Within the 16 patients, regression analysis revealed an apparent association between drug induced changes in CS (r = .81, p<.001) and ophthalmic artery indices and between visual field sensitivity (r = -.55, p < .05) and central retinal artery resistive index. A significant correlation between age (r = -.64, p < .01) and ophthalmic artery indices was also noted at baseline. Conclusions. Nifedipine did not provide universal benefit for improving ocular blood flow velocity in NTG patients. Drug induced changes in ocular blood flow velocity may be related to changes in certain measures of visual function in some patients.

Original languageEnglish
JournalInvestigative Ophthalmology and Visual Science
Volume37
Issue number3
StatePublished - Feb 15 1996

Fingerprint

Low Tension Glaucoma
Nifedipine
Contrast Sensitivity
Hemodynamics
Visual Fields
Ophthalmic Artery
Blood Flow Velocity
Pharmaceutical Preparations
Therapeutics
Ciliary Arteries
Retinal Artery
Calcium Channels
Color
Heart Rate
Regression Analysis
Blood Pressure

ASJC Scopus subject areas

  • Ophthalmology

Cite this

@article{b5a070f274664c24a5047dca17ce1295,
title = "Changes in retrobulbar ocular hemodynamics and visual function in low tension glaucoma patients after six months of treatment with nifedipine",
abstract = "Purpose. Reduced ocular blood flow, possibly from ocular vasospasm, has been suggested as a cause for vision loss associated with normal-tension glaucoma (NTG). Calcium channel blocking agents have recently been proposed as treatment for ocular vasospasm. Methods. Color Doppler imaging (CDI) of the ophthalmic, central retinal and short posterior ciliary arteries, visual field sensitivity and static spatial contrast sensitivity were evaluated for sixteen NTG patients (9 Female/ 7 Male: Age 58.8 ± 15 years) after 3 weeks of drug washout and again following 6 months of treatment with nifedipine. Results. Nifedipine did not alter IOP, blood pressure or heart rate. The drug left peak systolic velocity, end diastolic velocity and resistive index in each retrobulbar vessel unaltered. Visual field sensitivity and contrast sensitivity (CS) at 3 spatial frequencies also showed no change. CS did, however, improve significantly at 6 cpd (p = .004). Within the 16 patients, regression analysis revealed an apparent association between drug induced changes in CS (r = .81, p<.001) and ophthalmic artery indices and between visual field sensitivity (r = -.55, p < .05) and central retinal artery resistive index. A significant correlation between age (r = -.64, p < .01) and ophthalmic artery indices was also noted at baseline. Conclusions. Nifedipine did not provide universal benefit for improving ocular blood flow velocity in NTG patients. Drug induced changes in ocular blood flow velocity may be related to changes in certain measures of visual function in some patients.",
author = "Evans, {D. W.} and Alon Harris and Louis Cantor and R. Wilson and Martin, {B. J.}",
year = "1996",
month = "2",
day = "15",
language = "English",
volume = "37",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - Changes in retrobulbar ocular hemodynamics and visual function in low tension glaucoma patients after six months of treatment with nifedipine

AU - Evans, D. W.

AU - Harris, Alon

AU - Cantor, Louis

AU - Wilson, R.

AU - Martin, B. J.

PY - 1996/2/15

Y1 - 1996/2/15

N2 - Purpose. Reduced ocular blood flow, possibly from ocular vasospasm, has been suggested as a cause for vision loss associated with normal-tension glaucoma (NTG). Calcium channel blocking agents have recently been proposed as treatment for ocular vasospasm. Methods. Color Doppler imaging (CDI) of the ophthalmic, central retinal and short posterior ciliary arteries, visual field sensitivity and static spatial contrast sensitivity were evaluated for sixteen NTG patients (9 Female/ 7 Male: Age 58.8 ± 15 years) after 3 weeks of drug washout and again following 6 months of treatment with nifedipine. Results. Nifedipine did not alter IOP, blood pressure or heart rate. The drug left peak systolic velocity, end diastolic velocity and resistive index in each retrobulbar vessel unaltered. Visual field sensitivity and contrast sensitivity (CS) at 3 spatial frequencies also showed no change. CS did, however, improve significantly at 6 cpd (p = .004). Within the 16 patients, regression analysis revealed an apparent association between drug induced changes in CS (r = .81, p<.001) and ophthalmic artery indices and between visual field sensitivity (r = -.55, p < .05) and central retinal artery resistive index. A significant correlation between age (r = -.64, p < .01) and ophthalmic artery indices was also noted at baseline. Conclusions. Nifedipine did not provide universal benefit for improving ocular blood flow velocity in NTG patients. Drug induced changes in ocular blood flow velocity may be related to changes in certain measures of visual function in some patients.

AB - Purpose. Reduced ocular blood flow, possibly from ocular vasospasm, has been suggested as a cause for vision loss associated with normal-tension glaucoma (NTG). Calcium channel blocking agents have recently been proposed as treatment for ocular vasospasm. Methods. Color Doppler imaging (CDI) of the ophthalmic, central retinal and short posterior ciliary arteries, visual field sensitivity and static spatial contrast sensitivity were evaluated for sixteen NTG patients (9 Female/ 7 Male: Age 58.8 ± 15 years) after 3 weeks of drug washout and again following 6 months of treatment with nifedipine. Results. Nifedipine did not alter IOP, blood pressure or heart rate. The drug left peak systolic velocity, end diastolic velocity and resistive index in each retrobulbar vessel unaltered. Visual field sensitivity and contrast sensitivity (CS) at 3 spatial frequencies also showed no change. CS did, however, improve significantly at 6 cpd (p = .004). Within the 16 patients, regression analysis revealed an apparent association between drug induced changes in CS (r = .81, p<.001) and ophthalmic artery indices and between visual field sensitivity (r = -.55, p < .05) and central retinal artery resistive index. A significant correlation between age (r = -.64, p < .01) and ophthalmic artery indices was also noted at baseline. Conclusions. Nifedipine did not provide universal benefit for improving ocular blood flow velocity in NTG patients. Drug induced changes in ocular blood flow velocity may be related to changes in certain measures of visual function in some patients.

UR - http://www.scopus.com/inward/record.url?scp=33750198800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750198800&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750198800

VL - 37

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -